Xiu et al., have reported that malignant B-cells produced IL-10 in NHL patients thus promoted the decrease in MHCII expression on monocytes and the increase in the percentage of CD14+HLA-DRlow/− cells [13]. This evidence concerns the gene CD14 and non-Hodgkin lymphoma.